Page 598«..1020..597598599600..610620..»

Comprehensive Report on Duchenne Muscular Dystrophy Treatment Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Santhera…

Posted: Published on September 29th, 2020

Duchenne Muscular Dystrophy Treatment Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Comprehensive Report on Duchenne Muscular Dystrophy Treatment Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Santhera…

Sareptas First Gene-Therapy Test Patients Look Good, 2 Years Out – Barron’s

Posted: Published on September 29th, 2020

Text size A question hanging over gene therapies, which attempt a once-and-done fix for genetic diseases, is will their benefits endure? Monday, Sarepta Therapeutics told a scientific conference that the first four children who got its investigational gene therapy, for Duchenne muscular dystrophy, all continued to show better-functioning muscles after two years Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Sareptas First Gene-Therapy Test Patients Look Good, 2 Years Out – Barron’s

Gene Therapy Stocks Continue To Underperform. Are They Worth A Look? – Trefis

Posted: Published on September 29th, 2020

Gene therapy which aims to treat diseases by essentially inserting a gene into a patients cells rather than via drugs or surgery was a hot trend in the biotech space, but investor interest in the sector appears to have died down considerably, on account of high R&D spending and delays companies have seen in launching revenue-generating products.Our indicative theme of Gene-Based Therapy Stocks is down by about -23% year-to-date, underperforming the S&P 500 which is up by about 2%. However, with valuations declining, these companies could be attractive bets for investors as years of investments potentially start to pay off. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Gene Therapy Stocks Continue To Underperform. Are They Worth A Look? – Trefis

Worse Long-Term Prognosis in Myocardial Infarction Occurring at Weekends or Public Holidays with Insight into Myocardial Infarction with…

Posted: Published on September 29th, 2020

Introduction:The weekend effect in Polish myocardial infarction (MI) patients treated in the current network of cathlabs is poorly understood. Continue reading

Posted in Myocardial Infarction | Comments Off on Worse Long-Term Prognosis in Myocardial Infarction Occurring at Weekends or Public Holidays with Insight into Myocardial Infarction with…

De Winter Syndrome as an Emergency Electrocardiogram Sign of ST-elevation Myocardial Infarction: A Case Report – DocWire News

Posted: Published on September 29th, 2020

The case report aims to reveal de Winters electrocardiogram (ECG) pattern as an equivalent to anterior ST-segment elevation myocardial infarction (STEMI). We report a case of a 49-year-old man with a history of smoking who presented to the emergency department with a 1 day history of chest pain that was exacerbated 5 h prior to presentation Continue reading

Posted in Myocardial Infarction | Comments Off on De Winter Syndrome as an Emergency Electrocardiogram Sign of ST-elevation Myocardial Infarction: A Case Report – DocWire News

Early Blood Pressure Assessment after Acute Myocardial Infarction: Insights Using Digital Health Technology – DocWire News

Posted: Published on September 29th, 2020

Objective:There is rising interest in digital health in preventive cardiology, particularly for blood pressure (BP) management. In a digital health study of early BP assessment following acute myocardial infarction (AMI), we sought to examine feasibility and the (1) proportion of post-AMI patients with controlled BP and hypotension, and (2) association between prior cardiovascular disease (CVD) and BP post-AMI. Methods:In this substudy of the parent Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) study, type 1 AMI patients were enrolled between October 2017 and April 2019 Continue reading

Posted in Myocardial Infarction | Comments Off on Early Blood Pressure Assessment after Acute Myocardial Infarction: Insights Using Digital Health Technology – DocWire News

World Heart Day: Why are heart attacks on the rise among young Indians? – The Financial Express

Posted: Published on September 29th, 2020

Individuals with age as low as 20-40 years have been seen to be affected by cardiovascular disorders (CVD). By Dr. Kamal Gupta Non- Communicable Diseases are posing a great threat for the Indian Healthcare system Continue reading

Posted in Myocardial Infarction | Comments Off on World Heart Day: Why are heart attacks on the rise among young Indians? – The Financial Express

Relation found between AMI and obesity < Hospital < – KBR – Korea Biomedical Review

Posted: Published on September 29th, 2020

() () URL() Local researchers said they have found a clue to explain the relationship between acute myocardial infarction (AMI) and obesity. Obesity is a major cause of AMI, but the relationship between visceral fat inflammatory activity, a key mechanism of obesity, and acute myocardial infarction has not been identified so far. On Tuesday, Professor Kim Sung-eun at the Department of Nuclear Medicine of Korea University Anam Hospital and her colleagues said they have found that the inflammatory activity of visceral fat was high in patients with AMI and that it was closely associated with atherosclerotic inflammation of the carotid artery. Continue reading

Posted in Myocardial Infarction | Comments Off on Relation found between AMI and obesity < Hospital < – KBR – Korea Biomedical Review

Study Identifies Risks of Nonfatal Cardiovascular Disease Events in Patients with Lupus – BioSpace

Posted: Published on September 29th, 2020

NEW YORK, Sept. 29, 2020 /PRNewswire/ -- Patients with systemic lupus erythematosus (SLE) have a 27% higher risk of having a nonfatal cardiovascular disease (CVD) event compared to age- and sex-matched diabetes mellitus (DM) patients and more than twice the risk of the Medicaid general population, according to a new study led by a researcher at Hospital for Special Surgery (HSS) in New York City. Continue reading

Posted in Myocardial Infarction | Comments Off on Study Identifies Risks of Nonfatal Cardiovascular Disease Events in Patients with Lupus – BioSpace

Effectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure After Myocardial Infarction: A Clinical Study – DocWire News

Posted: Published on September 29th, 2020

Introduction:Silent heart failure after myocardial infarction has not been effectively treated. Atorvastatin has certain efficacy in the treatment of heart failure. Our clinical study aimed to investigate the effectiveness of atorvastatin in patients with asymptomatic heart failure after myocardial infarction. Continue reading

Posted in Myocardial Infarction | Comments Off on Effectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure After Myocardial Infarction: A Clinical Study – DocWire News

Page 598«..1020..597598599600..610620..»